By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Stemline Therapeutics, Inc. 

1675 York Avenue
Suite 30-E
New York  New York  10128  U.S.A.
Phone: 212-831-1111 Fax:


SEARCH JOBS








Company News
Stemline Therapeutics, Inc. (STML) Provides Second Quarter 2014 Financial Results And Corporate Update 8/14/2014 7:33:50 AM
Stemline Therapeutics, Inc. (STML) To Present At The Wedbush Life Sciences Management Access Conference 8/5/2014 8:13:08 AM
Stemline Therapeutics, Inc. (STML) Announces Opening Of SL-401 Corporate IND And Start Of Clinical Trials In BPDCN And AML 7/28/2014 7:46:22 AM
Stemline Therapeutics, Inc. (STML) To Present At The 2014 Wells Fargo Securities Healthcare Conference 6/10/2014 9:48:08 AM
Stemline Therapeutics, Inc. (STML) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/28/2014 9:56:21 AM
Stemline Therapeutics, Inc. (STML) Announces Presentation Of SL-401 Preclinical Efficacy Data In Multiple Myeloma At The 2014 American Society of Clinical Oncology Annual Meeting 5/20/2014 9:29:26 AM
Stemline Therapeutics, Inc. (STML) To Present At The Deutsche Bank (DB) 39th Annual Health Care Conference 4/30/2014 9:38:22 AM
Stemline Therapeutics, Inc. (STML) Announces FDA Acceptance Of IND For SL-701, A Synthetic Multi-Peptide Vaccine Targeting Glioma Brain Tumors 4/8/2014 7:39:18 AM
Stemline Therapeutics, Inc. (STML) To Present At The 13th Annual Needham Healthcare Conference 4/7/2014 9:03:48 AM
Stemline Therapeutics, Inc. (STML) Announces Presentation Of SL-501 Preclinical Efficacy Data In TKI-Resistant CML At The Annual Meeting Of The American Association for Cancer Research 4/1/2014 10:20:00 AM
123456
//-->